Cargando…
Pharmacological Approaches to Delaying Disability Progression in Patients with Multiple Sclerosis
In individuals with multiple sclerosis, physical and cognitive disability progression are clinical and pathophysiological hallmarks of the disease. Despite shortcomings, particularly in capturing cognitive deficits, the Expanded Disability Status Scale is the assessment of disability progression mos...
Autores principales: | Wiendl, Heinz, Meuth, Sven G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464731/ https://www.ncbi.nlm.nih.gov/pubmed/26033077 http://dx.doi.org/10.1007/s40265-015-0411-0 |
Ejemplares similares
-
Beyond the Magic Bullet: Current Progress of Therapeutic Vaccination in Multiple Sclerosis
por: Willekens, Barbara, et al.
Publicado: (2018) -
Bruton’s Tyrosine Kinase Inhibitors in Multiple Sclerosis: Pioneering the Path Towards Treatment of Progression?
por: Geladaris, Anastasia, et al.
Publicado: (2022) -
Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond
por: Ruck, Tobias, et al.
Publicado: (2015) -
New Pharmacological Approaches to the Management of Premenstrual Dysphoric Disorder
por: Sundström-Poromaa, Inger, et al.
Publicado: (2023) -
Enhancing Mood, Cognition, and Quality of Life in Pediatric Multiple Sclerosis
por: Fernandez-Carbonell, Cristina, et al.
Publicado: (2021)